Pages that link to "Q68015408"
Jump to navigation
Jump to search
The following pages link to Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria (Q68015408):
Displaying 23 items.
- Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants (Q34568807) (← links)
- Graded effects of proteinuria on HDL structure in nephrotic rats (Q34586564) (← links)
- Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms (Q35106762) (← links)
- A case of membranous glomerulonephritis presenting as pulmonary embolism and acute hyperlipidaemia (Q35586249) (← links)
- Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney Disease. (Q35868708) (← links)
- Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome (Q36729267) (← links)
- The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia (Q37693614) (← links)
- Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease (Q38388185) (← links)
- Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences (Q38831462) (← links)
- Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies (Q39592097) (← links)
- Lipids and the kidney (Q40653054) (← links)
- Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment (Q40725226) (← links)
- Gene expression of hepatic cholesterol 7 alpha-hydroxylase in the course of puromycin-induced nephrosis (Q42556138) (← links)
- Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis (Q43495854) (← links)
- The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria (Q43654234) (← links)
- Down-regulation of hepatic LDL receptor expression in experimental nephrosis (Q45173451) (← links)
- Plasma triglyceride levels are higher in nephrotic than in analbuminemic rats despite a similar increase in hepatic triglyceride secretion (Q51591057) (← links)
- Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk (Q64108327) (← links)
- The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment (Q71094677) (← links)
- Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia (Q72171827) (← links)
- Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria (Q72664928) (← links)
- Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells (Q72758265) (← links)
- Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation (Q73740070) (← links)